Nutraceutical ingredients supplier Maypro Group has received a minority investment from Marubeni America Corporation, the US subsidiary of Marubeni Corporation of Japan.
Maypro hopes the investment will help the company towards being the nutraceutical industry’s leading global supplier.
Marubeni and Maypro said they also intend to explore opportunities for joint projects in the nutraceutical and food industries where synergies between the two companies exist.
The two companies said they seek to capitalise on the rapid growth of the $200bn global health nutrition industry supported by favourable demographic trends, including an aging population, particularly in the US, Japan and Europe, and growing consumer spending on “wellness” products worldwide.
“The participation of Marubeni in our growth initiatives represents an important development in our mission to be the leading global diversified supplier of high-quality nutraceutical ingredients,” said Steve Yamada, president and CEO of Maypro. “Over the past three decades, we have significantly grown our ingredients business, developed a strong portfolio
of patented, branded products and expanded our operations in the US, Japan and China to build a truly global platform, which we are now seeking to further expand with Marubeni’s support.”
“In Maypro, we were attracted by its position in the nutraceutical industry and the superior management team assembled in major markets around the world,” said Tsutomu Yamamoto, the executive vice-president and COO of Marubeni America Corporation. “Consumers care more about their health in this day and age. We expect this industry to continue its steady growth. Furthermore, we intend to work with Maypro in identifying mutually beneficial opportunities.”
